Sanofi is considering cutting hundreds of jobs and will discuss potential steps with staff representatives over the coming days, five sources said this week. Management has begun meeting with staff representatives to outline a restructuring plan, five sources familiar with the matter told Reuters. They declined to be identified as the plan is still confidential. The reorganization could involve several European countries and possibly others outside the region, as well as all the divisions of Sanofi except the vaccines and rare diseases unit Genzyme, the sources said. Three sources said around 1,000 jobs in France were at risk. Learn More